Table 1 –
Blood analysis from healthy and SCA participants. The baseline %SpO2 was the average SpO2 in the year prior to this study.
| Age (y) | Gender | Baseline %SpO2 | %Hct | %HbA | %HbS | %HbF | %MetHb | %COHb | pH Range | |
|---|---|---|---|---|---|---|---|---|---|---|
| Controls | 33 | F | N/A | 40.4 | 100 | 0 | 0 | 0.9 | 0.8 | 7.18–7.36 |
| 52 | M | N/A | 42.6 | 100 | 0 | 0 | 1 | 1 | 7.22–7.38 | |
| 40 | F | N/A | 38.7 | 100 | 0 | 0 | 1 | 1.2 | 7.18–7.51 | |
| 45 | M | N/A | 42.5 | 100 | 0 | 0 | 0.7 | 0.7 | 7.31–7.42 | |
| 35 | M | N/A | 41.6 | 100 | 0 | 0 | 0.8 | 1.1 | 7.30–7.39 | |
| 24 | M | N/A | 42.5 | 100 | 0 | 0 | 1.8 | 1 | 7.36–7.40 | |
| μ±σ | 38.2±9.8 | - | 41.4±1.6 | 100±0 | 0±0 | 0±0 | 1±0.4 | 1±0.2 | - | |
| SCA | 41 | F | 98.7 | 21.7 | 3 | 78.8 | 18.2 | 1.7 | 3.5 | 7.33–7.36 |
| 39 | M | 88.5 | 18 | 29 | 64.6 | 6.4 | 2.8 | 5 | 7.32–7.38 | |
| 25 | M | 95.3 | 29.7 | 2.6 | 81.9 | 15.5 | 3.4 | 10.1 | 7.42–7.47 | |
| 22 | F | 97.0 | 22 | 3.7 | 89.1 | 7.2 | 3.1 | 3.2 | 7.30–7.39 | |
| 25 | F | 95.7 | 19.2 | 3.5 | 93.8 | 2.7 | 1.8 | 4.5 | 7.26–7.39 | |
| 18 | M | 96.5 | 28.5 | 2.1 | 77.7 | 20.2 | 1.4 | 3.6 | 7.27–7.44 | |
| μ±σ | 28.3±9.4 | - | 95.3±3.5 | 23.2±4.8* | 7.3±10.6* | 81±10.1* | 11.7±7.2* | 2.4±0.8* | 5±2.6* | - |